Mobile

A study done to determine the concentration of the investigational drug, perampanel (E2007) (called, "Study Drug") in the child's blood over a period of time

Update Il y a 4 ans
Reference: EUCTR2013-005391-17

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of the study is to evaluate the PK of perampanel during the Maintenance Period of the Core Study following oral suspension administration given as an adjunctive therapy in pediatric subjects from 1 month to less than 24 months (<2 years) of age with epilepsy.

Inclusion criteria

  • This study is to investigate the pharmacokinetics (PK) of perampanel in pediatric subjects from age ≥1 to <24 months (<2 years)

Links